Yesil M - Search Results

1

Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.

Toprak O, Cirit M, Yesil M, Bayata S, Tanrisev M, Varol U, Ersoy R, Esi E. Toprak O, et al. Among authors: yesil m. Nephrol Dial Transplant. 2007 Mar;22(3):819-26. doi: 10.1093/ndt/gfl636. Epub 2006 Nov 7. Nephrol Dial Transplant. 2007. PMID: 17090607

2

[The effect of pre-procedural captopril on contrast-induced nephropathy in patients who underwent coronary angiography].

Toprak O, Cirit M, Bayata S, Yeşil M, Aslan SL. Toprak O, et al. Among authors: yesil m. Anadolu Kardiyol Derg. 2003 Jun;3(2):98-103. Anadolu Kardiyol Derg. 2003. PMID: 12826500 Clinical Trial. Turkish.

3

[Review of the radiocontrast nephropathy risk profiles and risk stratification].

Toprak O, Cirit M, Bayata S, Yeşil M. Toprak O, et al. Among authors: yesil m. Anadolu Kardiyol Derg. 2004 Dec;4(4):331-5. Anadolu Kardiyol Derg. 2004. PMID: 15590363 Review. Turkish.

4

Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.

Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Toprak O, et al. Among authors: yesil m. Catheter Cardiovasc Interv. 2006 Feb;67(2):227-35. doi: 10.1002/ccd.20598. Catheter Cardiovasc Interv. 2006. PMID: 16400673

5

Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment.

Toprak O, Cirit M, Yesil M, Byrne DW, Postaci N, Bayata S, Majchrzak KM, Esi E. Toprak O, et al. Among authors: yesil m. Kidney Blood Press Res. 2006;29(1):2-9. doi: 10.1159/000092481. Epub 2006 Mar 22. Kidney Blood Press Res. 2006. PMID: 16582571

6

Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.

Cirit M, Toprak O, Yesil M, Bayata S, Postaci N, Pupim L, Esi E. Cirit M, et al. Among authors: yesil m. Nephron Clin Pract. 2006;104(1):c20-7. doi: 10.1159/000093255. Epub 2006 May 9. Nephron Clin Pract. 2006. PMID: 16685140

7

The role of nebivolol in the prevention of contrast-induced nephropathy in patients with renal dysfunction.

Avci E, Yeşil M, Bayata S, Postaci N, Arikan E, Cirit M. Avci E, et al. Among authors: yesil m. Anadolu Kardiyol Derg. 2011 Nov;11(7):613-7. doi: 10.5152/akd.2011.164. Epub 2011 Sep 29. Anadolu Kardiyol Derg. 2011. PMID: 21959875 Clinical Trial.

8

Can we predict the severity of coronary artery disease in patients with stable angina using NT-ProBNP?

Yeşil M, Postaci N, Arikan E, Ceylan O, Bayata S, Köseoğlu M. Yeşil M, et al. Anadolu Kardiyol Derg. 2006 Sep;6(3):235-8. Anadolu Kardiyol Derg. 2006. PMID: 16943107

9

Locations of coronary artery lesions in patients with severe conduction disturbance.

Yesil M, Arikan E, Postaci N, Bayata S, Yilmaz R. Yesil M, et al. Int Heart J. 2008 Sep;49(5):525-31. doi: 10.1536/ihj.49.525. Int Heart J. 2008. PMID: 18971564 Free article.

10

Is there an association between left bundle branch block and coronary slow flow in patients with normal coronary arteries?

Biceroglu S, Yildiz A, Bayata S, Yesil M, Postaci N. Biceroglu S, et al. Among authors: yesil m. Angiology. 2007 Dec-2008 Jan;58(6):685-8. doi: 10.1177/0003319707308893. Epub 2007 Nov 7. Angiology. 2007. PMID: 17989421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters